Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 04, 2015 1:15 PM ET

Biotechnology

Company Overview of Kolltan Pharmaceuticals, Inc.

Key Executives for Kolltan Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Gerald McMahon Ph.D.28 RelationshipsChief Executive Officer, President and Director60
Arthur G. Altschul Jr.38 RelationshipsCo-Founder and Chairman of the Board50
Joseph P. Schlessinger Ph.D.72 RelationshipsCo-Founder, Chairman of Scientific Advisory Board, Chief Scientist and Director70
Jane Pritchett V. Henderson 14 RelationshipsChief Financial & Business Officer and Senior Vice President49
Theresa M. Lavallee Ph.D.No RelationshipsSenior Vice President of Translational Medicine & Product Development49
View More Key Executives

Kolltan Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Arthur G. Altschul Jr. 38 RelationshipsKolltan Pharmaceuticals, Inc.50
Gerald McMahon Ph.D. 28 RelationshipsKolltan Pharmaceuticals, Inc.60
Axel Bolte M.Sc., M.B.A. 33 RelationshipsHBM Partners Ltd.43
Joseph P. Schlessinger Ph.D. 72 RelationshipsKolltan Pharmaceuticals, Inc.70
K. Peter Hirth Ph.D. 96 RelationshipsTrovaGene, Inc.63
View All Board Members

Kolltan Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D.Joseph P. Schlessinger72 Relationships8 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$400.0K
400.0K
359.2K
Bonus
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$400.0K
400.0K
30.1M
Compensation as of Fiscal Year 2013
Kolltan Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

PURE Bioscience, Inc. Announces Executive Changes
July 31, 2015 1:49 PM ET
China Ludao Technology Company Limited Announces Change in Directorships
July 31, 2015 11:46 AM ET
Carewell Industries Limited Announces Management Changes
July 31, 2015 10:03 AM ET
Aunt Fannie's Appoints Mark Haas to Advisory Board
July 31, 2015 8:56 AM ET
The Procter & Gamble Company Announces Executive Changes
July 28, 2015 9:53 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Kolltan Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.